Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 458
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 96
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
HIV/AIDS Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,424 Results (Page 62 of 122)
- Relevance
  Sort by

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030

 Report
February 2025
100 Pages
Global

From

€5294EUR$5,950USD£4,571GBP

Hypopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
May 2022
168 Pages
Global

From

€1779EUR$2,000USD£1,536GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Genitourinary Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4004EUR$4,500USD£3,457GBP

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

 Report
August 2025
181 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pleurodynia Treatment - Global Strategic Business Report

 Report
August 2025
270 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

High Potency APIs (HPAPIs) - Global Strategic Business Report

 Report
August 2025
192 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

 Drug Pipelines
August 2020
693 Pages
Global

From

€1779EUR$2,000USD£1,536GBP

Antidepressants Drugs Market by Drug Class (Atypical Antidepressant, Monoamine Oxidase Inhibitor, Selective Serotonin Reuptake Inhibitor), Product Type (Branded, Generic), Administration Route, Distribution Channel, Therapeutic Application - Global Forecast 2025-2030

 Report
August 2025
194 Pages
Global

From

€3154EUR$3,545USD£2,723GBP

€3504EUR$3,939USD£3,026GBP

Major Depressive Disorder - Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2669EUR$3,000USD£2,305GBP

Industry Snapshots: US Pharmaceuticals

 Newsletter
August 2025
50 Pages
United States

From

€214EUR$240USD£184GBP

Industry Snapshots: UK Pharmaceuticals

 Newsletter
August 2025
50 Pages
United Kingdom

From

€214EUR$240USD£184GBP

Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

 Report
December 2023
137 Pages
Global

From

€2202EUR$2,475USD£1,901GBP

€4404EUR$4,950USD£3,803GBP

Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Asia Pacific

From

€4226EUR$4,750USD£3,649GBP

Europe Sodium-dependent Glucose Cotransporter 2 - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Europe

From

€4226EUR$4,750USD£3,649GBP

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
100 Pages
Global

From

€4226EUR$4,750USD£3,649GBP

Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Drug Pipelines
March 2024
210 Pages
Global

From

€7073EUR$7,950USD£6,107GBP

Rheumatoid Arthritis - Pipeline Review, H2 2020

 Drug Pipelines
July 2020
1191 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Retinal Drugs Market 2025-2029

 Report
April 2025
217 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1777EUR$1,997USD£1,534GBP

2,424 Results (Page 62 of 122)
- 1
- 60
- 61
- 62
- 63
- 64

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.